Clinical Trial Update: A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration [Phase 4]

View source ↗

Summary

This Phase 4 trial studied blood levels of aflibercept after high-dose injections in both eyes for diabetic macular edema or neovascular age-related macular deg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Diabetic Macular Edema, Neovascular Age-related Macular Degeneration | Phase 4 | Status: COMPLETED